Casey Kathleen Beuerlein, FNP

Casey Beuerlein practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Casey Beuerlein's NPI, 1699286450, was assigned on October 19, 2017. Casey Beuerlein holds California license 95007634.

Casey Beuerlein's primary practice is Cedars-Sinai Medical Care Foundation, at 8767 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Casey Beuerlein's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Casey Beuerlein is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Casey Beuerlein to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Casey Beuerlein practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Casey Beuerlein's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Casey Beuerlein is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, chronic diabetes, cold sores or genital herpes, conjunctivitis, contact dermatitis, eyelid inflammation and high cholesterol among the conditions Casey Beuerlein treats.

CMS data shows 28 Medicare services from Casey Beuerlein across 1 procedure code in 2024, all of them office visits, for 46 Medicare patients. Medicare paid $2,060 for them. Every service was in an office.

CMS counts 46 Medicare patients who saw Casey Beuerlein in 2024. The largest group is 65 to 74, with 22 patients. 63% of them have high cholesterol, and 54% have arthritis. 28% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Casey Beuerlein's median patient age at 41, with 62% women.

In 2024, Casey Beuerlein wrote 170 Medicare Part D claims for 61 patients. 83% of them were for generic drugs. CMS names the drug for 35 of them, across 3 drugs with 11 or more claims each, at $1,899 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Casey Beuerlein for performance year 2024, reported as part of a group. Casey Beuerlein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.